GSK-201312

Study Sponsor: GSK

Study Title

A Multi-Centre, Open-Label, Study of Mepolizumab in a Subset of Subjects with a History of Life Threatening/Seriously Debilitating Asthma Who Participated in the MEA115661 Trial

Medicine or Vaccine (generic name)

mepolizumab

Sponsor Identification Number

201312

Trial Registry Identification Number(#'s)

NCT02135692 2014-000314-54

Medical Condition

Asthma

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=201312

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02135692

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2014-000314-54

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study is linked to study MEA115661. This study is available in CDISC format.

Date Added to this Site

September 2019